| Maternal obesity and the intergenerational risk of cancer : Epidemiologic evidence and mechanistic insights | Cancer epidemiology |  | | 2026 | 24 | 153 |
|
| Reply : Timing shapes adjuvant PD-1 efficacy after hepatectomy in HCC | Hepatology |  | | 2025 | 19 | 0 |
|
| Impact of portosystemic shunt on hepatocellular carcinoma | | | | 2025 | 119 | 1 |
|
| Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation : An international retrospective cohort study | Hepatology | | | 2025 | 106 | 2,004 |
|
| Hepatectomy alters adjuvant anti-PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy | Hepatology | | | 2025 | 55 | 1 |
|
| Transjugular Intrahepatic Portosystemic Shunt Is Associated With Better Waitlist Management of Liver Transplant Candidates With Hepatocellular Carcinoma | Transplant international | | | 2024 | 89 | 219 |
|
| Maternal obesity increases the risk of hepatocellular carcinoma through the transmission of an altered gut microbiome | JHEP reports | | | 2024 | 175 | 285 |
|
| Anti-CD122 antibody restores specific CD8+ T cell response in nonalcoholic steatohepatitis and prevents hepatocellular carcinoma growth | Oncoimmunology | | | 2023 | 151 | 233 |
|
| Immunotherapy and liver transplantation : a narrative review of basic and clinical data | Cancers | | | 2023 | 104 | 849 |
|
| Preoperative platelet count does not predict the occurrence of post-hepatectomy liver failure after partial hepatectomy in a retrospective monocentric cohort study | Medicine (Baltimore) | | | 2021 | 280 | 163 |
|
